secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001193125-25-145741
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viridian shareholders approve 8M-share increase in equity plan in close vote
----------------------------------------------------------------------------

- Stockholders narrowly approved amendment to increase equity plan shares by 8,000,000 (35.3M for, 35.1M against).
- Three Class I directors elected: Jeff Ajer, Chris Cain, Sarah Gheuens.
- Ratification of KPMG as auditor, advisory say-on-pay, and 2025 ESPP all passed.
- Close 49.8% opposition on equity plan reflects significant shareholder dissent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312525145741/0001193125-25-145741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312525145741/d871650d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-145741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer